©The Author(s) 2025.
World J Hepatol. Dec 27, 2025; 17(12): 112835
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.112835
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.112835
Figure 4 He-He-Shu-Yang formula inhibits the nicotinamide adenine dinucleotide phosphate oxidase 4/reactive oxygen species/nu cleotide binding oligomerization domain-like receptor family pyrin domain-containing 3 inflammasome pathway in rats with carbon tetrachloride-induced fibrosis.
bP < 0.01 vs control group; dP < 0.01 vs model group. A: Representative images of nicotinamide adenine dinucleotide phosphate oxidase 4 immunohistochemistry staining in each group (bar = 100 μm); the brown area shows nicotinamide adenine dinucleotide phosphate oxidase 4 expression; B: Serum level of superoxide anion (O2-) in each group; C: Serum level of hydrogen peroxide (H2O2) in each group; D: Hydroxyl radical (OH) clearance rate in each group; E: Representative images of nucleotide binding oligomerization domain-like receptor family pyrin domain-containing 3 immunohistochemistry staining (bar = 100 μm); F: Protein levels of nucleotide binding oligomerization domain-like receptor family pyrin domain-containing 3 and cleaved caspase-1 in the different groups, as determined using western blotting. HHSY: He-He-Shu-Yang formula; NOX4: Nicotinamide adenine dinucleotide phosphate oxidase 4; NLRP3: Nucleotide binding oligomerization domain-like receptor family pyrin domain-containing 3.
- Citation: Zeng FL, Shi MJ, Mo YS, Xiao HM, Xie YB, Chi XL. He-He-Shu-Yang formula alleviates liver fibrosis by inhibiting hepatic stellate cell activation in vivo and in vitro. World J Hepatol 2025; 17(12): 112835
- URL: https://www.wjgnet.com/1948-5182/full/v17/i12/112835.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i12.112835